Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Nabriva Therapeutics Plc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nabriva Therapeutics Plc market cap is $300.00.
What is the 52-week high for Nabriva Therapeutics Plc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nabriva Therapeutics Plc 52 week high is $0.01 as of October 10, 2025.
What is the 52-week low for Nabriva Therapeutics Plc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nabriva Therapeutics Plc 52 week low is $0.00 as of October 10, 2025.
What is Nabriva Therapeutics Plc stock price today?
Nabriva Therapeutics Plc stock price today is $0.0001.
What was Nabriva Therapeutics Plc stock price yesterday?
Nabriva Therapeutics Plc stock price yesterday was $0.0001.
What is the 50-day moving average of Nabriva Therapeutics Plc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nabriva Therapeutics Plc 50-day moving average is $0.0001.